Slingshot members are tracking this event:
FDA reviewers support Celltrion's biosimilar Remicade, ahead of the Ad Comm meeting on February 9
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Feb 05, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Remicade, Biosimilar, Remsima, Rheumatoid Arthritis, Crohn's Disease, Inflammatory Bowel Conditions